268 related articles for article (PubMed ID: 2554366)
1. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
Graff G; Anderson LA
Prostaglandins; 1989 Oct; 38(4):473-96. PubMed ID: 2554366
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG
Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages.
Laviolette M; Carreau M; Coulombe R; Cloutier D; Dupont P; Rioux J; Braquet P; Borgeat P
J Immunol; 1988 Sep; 141(6):2104-9. PubMed ID: 2844895
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of leukotriene (LT) and hydroxy eicosatetraenoic acid (HETE) synthesis in human leukocytes in vitro: effect of arachidonic acid concentration.
Fruteau de Laclos B; Braquet P; Borgeat P
Prostaglandins Leukot Med; 1984 Jan; 13(1):47-52. PubMed ID: 6324240
[TBL] [Abstract][Full Text] [Related]
5. Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils.
Betts WH; Hurst NP; Murphy GA; Cleland LG
Biochem Pharmacol; 1990 Apr; 39(7):1233-7. PubMed ID: 2157444
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibitory effects of auranofin on leukotriene B4 and leukotriene C4 formation by human polymorphonuclear leukocytes.
Honda Z; Iizasa T; Morita Y; Matsuta K; Nishida Y; Miyamoto T
Biochem Pharmacol; 1987 May; 36(9):1475-81. PubMed ID: 3034290
[TBL] [Abstract][Full Text] [Related]
7. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
8. Preferential inhibition of 5-lipoxygenase activity by manoalide.
De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA
Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 5- and 15-lipoxygenase activities in blood and alveolar leukocyte preparations from normal subjects and patients with eosinophilia.
Laviolette M; Picard S; Braquet P; Borgeat P
Prostaglandins Leukot Med; 1986 Aug; 23(2-3):191-9. PubMed ID: 3020586
[TBL] [Abstract][Full Text] [Related]
10. Modulation of alveolar macrophage-derived 5-lipoxygenase products by the sulfhydryl reactant, N-ethylmaleimide.
Peters-Golden M; Shelly C
J Biol Chem; 1987 Aug; 262(22):10594-600. PubMed ID: 3112148
[TBL] [Abstract][Full Text] [Related]
11. Effect of indomethacin on arachidonic acid metabolism in human leukocytes stimulated ex vivo.
Docherty JC; Wilson TW
Clin Pharmacol Ther; 1991 Mar; 49(3):294-9. PubMed ID: 1848800
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of leukotriene formation in human leukocytes by halothane.
Yamaoka A; Sumimoto H; Takeshige K; Itoh T; Isobe R; Yoshitake J; Minakami S
Biochim Biophys Acta; 1987 Apr; 918(3):284-92. PubMed ID: 3032266
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW
Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314
[TBL] [Abstract][Full Text] [Related]
14. Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.
Schröder JM
J Invest Dermatol; 1986 Nov; 87(5):624-9. PubMed ID: 3021863
[TBL] [Abstract][Full Text] [Related]
15. Production of metabolic products of arachidonic acid during cell-cell interactions.
Marcus AJ; Safier LB; Broekman MJ; Ullman HL; Islam N; Sorrell TC; Serhan CN; Weissmann G; Oglesby TD; Gorman RR
J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):338-42. PubMed ID: 6088611
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations.
Antoine C; Murphy RC; Henson PM; Maclouf J
Biochim Biophys Acta; 1992 Oct; 1128(2-3):139-46. PubMed ID: 1329972
[TBL] [Abstract][Full Text] [Related]
17. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
Tornhamre S; Edenius C; Smedegård G; Sjöquist B; Lindgren JA
Eur J Pharmacol; 1989 Oct; 169(2-3):225-34. PubMed ID: 2572437
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils.
Fogh K; Herlin T; Kragballe K
Arch Dermatol Res; 1988; 280(7):430-6. PubMed ID: 2849922
[TBL] [Abstract][Full Text] [Related]
19. Production of arachidonic acid lipoxygenase products during platelet-neutrophil interactions.
Marcus AJ; Broekman MJ; Safier LB; Ullman HL; Islam N; Serhan CN; Weissmann G
Clin Physiol Biochem; 1984; 2(2-3):78-83. PubMed ID: 6435929
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of 5-lipoxygenase activity in polymorphonuclear leukocytes of rats by caseinate treatment.
Chang WC; Su GW
Biochem Pharmacol; 1987 Sep; 36(18):3033-6. PubMed ID: 2820429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
